<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName archivearticle3.dtd?><?SourceDTD.Version 3.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Anat</journal-id><journal-id journal-id-type="iso-abbrev">J. Anat</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1469-7580</journal-id><journal-id journal-id-type="publisher-id">JOA</journal-id><journal-title-group><journal-title>Journal of Anatomy</journal-title></journal-title-group><issn pub-type="ppub">0021-8782</issn><issn pub-type="epub">1469-7580</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4832326</article-id><article-id pub-id-type="pmid">26612825</article-id><article-id pub-id-type="doi">10.1111/joa.12416</article-id><article-id pub-id-type="publisher-id">JOA12416</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Distinct expression patterns for type <styled-content style="fixed-case">II</styled-content> topoisomerases IIA and IIB in the early foetal human telencephalon</article-title><alt-title alt-title-type="left-running-head">L. F. Harkin et&#x000a0;al.</alt-title></title-group><contrib-group><contrib id="joa12416-cr-0001" contrib-type="author"><name><surname>Harkin</surname><given-names>Lauren F.</given-names></name><xref ref-type="aff" rid="joa12416-aff-0001"><sup>1</sup>
</xref><xref ref-type="aff" rid="joa12416-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="joa12416-cr-0002" contrib-type="author"><name><surname>Gerrelli</surname><given-names>Dianne</given-names></name><xref ref-type="aff" rid="joa12416-aff-0003">
<sup>3</sup>
</xref></contrib><contrib id="joa12416-cr-0003" contrib-type="author"><name><surname>Gold Diaz</surname><given-names>Diana C.</given-names></name><xref ref-type="aff" rid="joa12416-aff-0003">
<sup>3</sup>
</xref></contrib><contrib id="joa12416-cr-0004" contrib-type="author"><name><surname>Santos</surname><given-names>Chloe</given-names></name><xref ref-type="aff" rid="joa12416-aff-0003">
<sup>3</sup>
</xref></contrib><contrib id="joa12416-cr-0005" contrib-type="author"><name><surname>Alzu'bi</surname><given-names>Ayman</given-names></name><xref ref-type="aff" rid="joa12416-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="joa12416-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="joa12416-cr-0006" contrib-type="author" corresp="yes"><name><surname>Austin</surname><given-names>Caroline A.</given-names></name><xref ref-type="aff" rid="joa12416-aff-0004">
<sup>4</sup>
</xref></contrib><contrib id="joa12416-cr-0007" contrib-type="author" corresp="yes"><name><surname>Clowry</surname><given-names>Gavin J.</given-names></name><xref ref-type="aff" rid="joa12416-aff-0001">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="joa12416-aff-0001"><label><sup>1</sup></label><named-content content-type="organisation-division">Institute of Neuroscience</named-content><institution>Newcastle University</institution><named-content content-type="city">Newcastle upon Tyne</named-content><country country="GB">UK</country></aff><aff id="joa12416-aff-0002"><label><sup>2</sup></label><named-content content-type="organisation-division">Institute of Genetic Medicine</named-content><institution>Newcastle University</institution><named-content content-type="city">Newcastle upon Tyne</named-content><country country="GB">UK</country></aff><aff id="joa12416-aff-0003"><label><sup>3</sup></label><named-content content-type="organisation-division">HDBR Resource</named-content><institution>UCL Institute of Child Health</institution><named-content content-type="city">London</named-content><country country="GB">UK</country></aff><aff id="joa12416-aff-0004"><label><sup>4</sup></label><named-content content-type="organisation-division">Institute for Cell and Molecular Biosciences</named-content><institution>Newcastle University</institution><named-content content-type="city">Newcastle upon Tyne</named-content><country country="GB">UK</country></aff><author-notes><corresp id="correspondenceTo"><label>*</label>
Correspondence<break/>
Dr Gavin Clowry, Institute of Neuroscience, Newcastle University, Framlington Place, Newcastle upon Tyne NE2 4HH, UK. E: <email>gavin.clowry@ncl.ac.uk</email><break/>
Prof. Caroline Austin, Institute of Cell and Molecular Biosciences, Newcastle University, Framlington Place, Newcastle upon Tyne NE2 4HH, UK. E: <email>caroline.austin@ncl.ac.uk</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>27</day><month>11</month><year>2015</year></pub-date><pub-date pub-type="ppub"><month>3</month><year>2016</year></pub-date><volume>228</volume><issue>3</issue><issue-id pub-id-type="doi">10.1111/joa.2016.228.issue-3</issue-id><fpage>452</fpage><lpage>463</lpage><history><date date-type="accepted"><day>15</day><month>10</month><year>2015</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2016 Anatomical Society <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2015 The Authors. <italic>Journal of Anatomy</italic> published by John Wiley &#x00026; Sons Ltd on behalf of Anatomical Society.</copyright-statement><license license-type="creativeCommonsBy"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:JOA-228-452.pdf"/><abstract id="joa12416-abs-0001"><title>Abstract</title><p>
<styled-content style="fixed-case">TOP</styled-content>2A and <styled-content style="fixed-case">TOP</styled-content>2B are type <styled-content style="fixed-case">II</styled-content> topoisomerase enzymes that have important but distinct roles in <styled-content style="fixed-case">DNA</styled-content> replication and <styled-content style="fixed-case">RNA</styled-content> transcription. Recently, <styled-content style="fixed-case">TOP</styled-content>2B has been implicated in the transcription of long genes in particular that play crucial roles in neural development and are susceptible to mutations contributing to neurodevelopmental conditions such as autism and schizophrenia. This study maps their expression in the early foetal human telencephalon between 9 and 12 post&#x02010;conceptional weeks. <styled-content style="fixed-case">TOP</styled-content>2A immunoreactivity was restricted to cell nuclei of the proliferative layers of the cortex and ganglionic eminences (<styled-content style="fixed-case">GE</styled-content>), including the ventricular zone and subventricular zone (<styled-content style="fixed-case">SVZ</styled-content>) closely matching expression of the proliferation marker <styled-content style="fixed-case">KI</styled-content>67. Comparison with sections immunolabelled for <styled-content style="fixed-case">NKX</styled-content>2.1, a medial <styled-content style="fixed-case">GE</styled-content> (MGE) marker, and <styled-content style="fixed-case">PAX</styled-content>6, a cortical progenitor cell and lateral <styled-content style="fixed-case">GE</styled-content> (LGE) marker, revealed that <styled-content style="fixed-case">TOP</styled-content>2A&#x02010;expressing cells were more abundant in MGE than the LGE. In the cortex, <styled-content style="fixed-case">TOP</styled-content>2B is expressed in cell nuclei in both proliferative (<styled-content style="fixed-case">SVZ</styled-content>) and post&#x02010;mitotic compartments (intermediate zone and cortical plate) as revealed by comparison with immunostaining for <styled-content style="fixed-case">PAX</styled-content>6 and the post&#x02010;mitotic neuron marker <styled-content style="fixed-case">TBR</styled-content>1. However, co&#x02010;expression with <styled-content style="fixed-case">KI</styled-content>67 was rare. In the <styled-content style="fixed-case">GE</styled-content>,<styled-content style="fixed-case"> TOP</styled-content>2B was also expressed by proliferative and post&#x02010;mitotic compartments. <italic>In situ</italic> hybridisation studies confirmed these patterns of expression, except that <italic><styled-content style="fixed-case">TOP</styled-content>2A </italic>
<styled-content style="fixed-case">mRNA</styled-content> is restricted to cells in the G2/M phase of division. Thus, during early development, <styled-content style="fixed-case">TOP</styled-content>2A is likely to have a role in cell proliferation, whereas <styled-content style="fixed-case">TOP</styled-content>2B is expressed in post&#x02010;mitotic cells and may be important in controlling expression of long genes even at this early stage.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="joa12416-kwd-0001">autism susceptibility genes</kwd><kwd id="joa12416-kwd-0002">cortical development</kwd><kwd id="joa12416-kwd-0003">DNA replication</kwd><kwd id="joa12416-kwd-0004">ganglionic eminences</kwd><kwd id="joa12416-kwd-0005">RNA transcription</kwd></kwd-group><funding-group><award-group><funding-source>(Joint MRC)/Wellcome Trust</funding-source><award-id>099175/Z/12/Z</award-id></award-group></funding-group><counts><page-count count="12"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>component-id</meta-name><meta-value>joa12416</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>March 2016</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.8.6 mode:remove_FC converted:22.04.2016</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="joa12416-sec-0001"><title>Introduction</title><p>The helical structure and supercoiling of DNA is essential for nuclear packaging; however, processes such as DNA replication and transcription require complete separation and partial separation of the strands, respectively. During transcription, the partial separation of the DNA allows RNA polymerase and transcription factors to access specific gene regions, creating tension in the DNA. Topoisomerase enzymes govern the topological state of DNA in both prokaryotic and eukaryotic cells, allowing unwinding of the DNA and relieving the torsional strain created by supercoiling (Nitiss, <xref rid="joa12416-bib-0036" ref-type="ref">2009a</xref>). Cells have type I and II topoisomerase enzymes. Type I topoisomerases (TOP1 and TOP3) are able to break a single strand of DNA, allowing the intact strand to pass through it before re&#x02010;joining the broken strand, whilst type II topoisomerases (TOP2) carry out ATP&#x02010;mediated strand breakage of one or both strands. Human topoisomerases comprise distinct alpha and beta isoforms (Austin &#x00026; Marsh, <xref rid="joa12416-bib-0002" ref-type="ref">1998</xref>). Topoisomerase poisons are effective anti&#x02010;cancer drugs as they prevent cell replication and induce apoptosis (Nitiss, <xref rid="joa12416-bib-0037" ref-type="ref">2009b</xref>).</p><p>In rodents, expression of Top2a and Top2b in the brain is higher during early embryogenesis compared with the later stages (Capranico et&#x000a0;al. <xref rid="joa12416-bib-0008" ref-type="ref">1992</xref>). However, there is a surge of Top2b expression in the brain of newborn mice that is not observed for Top2a or the marker of cell proliferation thymidylate synthase. Top2a expression is most apparent in&#x000a0;proliferating tissues whereas Top2b expression is not confined to regions of proliferation, suggesting a role for rodent Top2b outside of DNA replication (Capranico et&#x000a0;al. <xref rid="joa12416-bib-0008" ref-type="ref">1992</xref>; Tsutsui et&#x000a0;al. <xref rid="joa12416-bib-0050" ref-type="ref">1993</xref>; Watanabe et&#x000a0;al. <xref rid="joa12416-bib-0053" ref-type="ref">1994</xref>). Top2b is the predominantly expressed topoisomerase enzyme in mouse neurons (Tiwari et&#x000a0;al. <xref rid="joa12416-bib-0049" ref-type="ref">2012</xref>), and has been shown to play a role in the development and lamination of the neocortex (Yang et&#x000a0;al. <xref rid="joa12416-bib-0058" ref-type="ref">2000</xref>; Lyu &#x00026; Wang, <xref rid="joa12416-bib-0030" ref-type="ref">2003</xref>). By E16.5, Top2b protein is found in the proliferative regions of the ventricular zone (VZ) and the subventricular zone (SVZ) of the mouse neocortex as well as in the post&#x02010;mitotic regions of the cortical plate (CP), subplate (SP) and marginal zone (MZ). Homozygous mutants exhibit abnormal cortical organisation at E16.5 with the SP being absent and the VZ appearing thickened compared with wild type (WT) (Lyu &#x00026; Wang, <xref rid="joa12416-bib-0030" ref-type="ref">2003</xref>). As these defects appear late in development and expression is seen in areas containing differentiated neurons, again this suggests a role for Top2b outside of DNA replication. Table&#x000a0;<xref rid="joa12416-tbl-0001" ref-type="table-wrap">1</xref> provides a summary of what is known about expression, localisation and function of type 2 isomerases in mouse and rat.</p><table-wrap id="joa12416-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p>Topoisomerase 2 nervous system expression, localisation and function in animal models</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" valign="top" colspan="1"/><th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Mouse</th><th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Rat</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Top2a</th><th align="left" valign="top" rowspan="1" colspan="1">Top2b</th><th align="left" valign="top" rowspan="1" colspan="1">Top2a</th><th align="left" valign="top" rowspan="1" colspan="1">Top2b</th></tr></thead><tbody><tr><td align="left" rowspan="3" colspan="1">Development</td><td align="left" rowspan="3" colspan="1">Mainly expressed in proliferative tissues (Capranico et&#x000a0;al. <xref rid="joa12416-bib-0008" ref-type="ref">1992</xref>)</td><td align="left" rowspan="1" colspan="1">Expressed in both proliferating and non&#x02010;proliferative tissues (Capranico et&#x000a0;al. <xref rid="joa12416-bib-0008" ref-type="ref">1992</xref>)</td><td align="left" rowspan="1" colspan="1">Transcripts highly expressed in embryonic brain but undetectable 4&#x02005;weeks after birth (Tsutsui et&#x000a0;al. <xref rid="joa12416-bib-0050" ref-type="ref">1993</xref>)</td><td align="left" rowspan="1" colspan="1">Transcripts present throughout embryonic and postnatal stages (Tsutsui et&#x000a0;al. <xref rid="joa12416-bib-0050" ref-type="ref">1993</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">An absence of Top2b affects cerebral stratification as well as causing a lack of axon innervation in skeletal muscles and spinal cord (Yang et&#x000a0;al. <xref rid="joa12416-bib-0058" ref-type="ref">2000</xref>; Lyu &#x00026; Wang, <xref rid="joa12416-bib-0030" ref-type="ref">2003</xref>)</td><td align="left" rowspan="1" colspan="1">In the developing cerebellum, Top2a expression is confined to proliferative layer (Tsutsui et&#x000a0;al. <xref rid="joa12416-bib-0050" ref-type="ref">1993</xref>)</td><td align="left" rowspan="1" colspan="1">In the developing cerebellum, Top2b expression is seen throughout cortical region (Tsutsui et&#x000a0;al. <xref rid="joa12416-bib-0050" ref-type="ref">1993</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">There is a shift from Top2a to Top2b expression during neuronal differentiation (Tiwari et&#x000a0;al. <xref rid="joa12416-bib-0049" ref-type="ref">2012</xref>)</td><td align="left" rowspan="1" colspan="1">Expressed in the VZ of embryonic brains (E13&#x02013;15) (Watanabe et&#x000a0;al. <xref rid="joa12416-bib-0053" ref-type="ref">1994</xref>)</td><td align="left" rowspan="1" colspan="1">Expressed throughout the brain from E13 to P21(Watanabe et&#x000a0;al. <xref rid="joa12416-bib-0053" ref-type="ref">1994</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">Maturity</td><td align="left" rowspan="1" colspan="1">Low expression in adult brain tissue relative to other tissues (Capranico et&#x000a0;al. <xref rid="joa12416-bib-0008" ref-type="ref">1992</xref>)</td><td align="left" rowspan="1" colspan="1">High expression in adult brain relative to other tissues (Capranico et&#x000a0;al. <xref rid="joa12416-bib-0008" ref-type="ref">1992</xref>)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="joa12416-note-0001"><p>VZ, ventricular zone.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><p>TOP2B has been implicated in transcriptional regulation in human cell lines (Ju et&#x000a0;al. <xref rid="joa12416-bib-0023" ref-type="ref">2006</xref>; Perillo et&#x000a0;al. <xref rid="joa12416-bib-0041" ref-type="ref">2008</xref>; Haffner et&#x000a0;al. <xref rid="joa12416-bib-0015" ref-type="ref">2010</xref>; McNamara et&#x000a0;al. <xref rid="joa12416-bib-0032" ref-type="ref">2010</xref>; Thakurela et&#x000a0;al. <xref rid="joa12416-bib-0048" ref-type="ref">2013</xref>; Isik et&#x000a0;al. <xref rid="joa12416-bib-0022" ref-type="ref">2015</xref>), and topoisomerases are known to be expressed in the developing and adult human brain (Zandvliet et&#x000a0;al. <xref rid="joa12416-bib-0059" ref-type="ref">1996</xref>; Plaschkes et&#x000a0;al. <xref rid="joa12416-bib-0042" ref-type="ref">2005</xref>). Evidence suggests that topoisomerase mutations can potentially affect the expression of susceptibility genes of neurodevelopmental disorders, including autism spectrum disorder (ASD; King et&#x000a0;al. <xref rid="joa12416-bib-0025" ref-type="ref">2013</xref>) Fragile X syndrome (Xu et&#x000a0;al. <xref rid="joa12416-bib-0056" ref-type="ref">2013</xref>) and mental retardation (Tarsitano et&#x000a0;al. <xref rid="joa12416-bib-0046" ref-type="ref">2014</xref>). It has been shown that TOP2B may be required for efficient transcription of a subset of long genes linked to ASD with roles in synapse formation and stabilisation (King et&#x000a0;al. <xref rid="joa12416-bib-0025" ref-type="ref">2013</xref>). This raises the possibility that topoisomerase proteins may have developmental roles in establishing the neural circuitry essential for the proper functioning of the human brain.</p><p>This study focusses on the expression of <italic>TOP2A</italic> and <italic>TOP2B</italic> in the developing human brain as they are highly expressed in neuronal cells. For the first time, the spatial expression of TOP2A and TOP2B was looked at across the developing human telencephalon from 9 to 12&#x02005;post&#x02010;conceptional weeks (PCW) using histochemical techniques. This time period covers the end of embryogenesis and the onset of the foetal stages, from the beginning of the formation of the CP but before thalamic afferents have innervated the cerebral cortex. In order to interpret these expression patterns more easily, nearby sections were immunostained for proteins that have been validated as markers for known human cell types/compartments (Bayatti et&#x000a0;al. <xref rid="joa12416-bib-0003" ref-type="ref">2008a</xref>; Pauly et&#x000a0;al. <xref rid="joa12416-bib-0040" ref-type="ref">2014</xref>), including PAX6 (radial glia), KI67 (dividing cells), TBR1 (early post&#x02010;mitotic cortical neurons) and NKX2.1 [progenitor cells of the medial ganglionic eminence (MGE)].</p></sec><sec id="joa12416-sec-0002"><title>Materials and methods</title><sec id="joa12416-sec-0003"><title>Human tissue</title><p>Human embryonic and foetal brain sections between 8 and 12&#x02005;PCW were obtained from the MRC&#x02010;Wellcome Trust Human Developmental Biology Resource (HDBR, <ext-link ext-link-type="uri" xlink:href="http://www.hdbr.org">http://www.hdbr.org</ext-link>). Brains were collected from terminations of pregnancy with maternal consent with the approval of local ethical committees. Age was determined by the assessment of external morphology (O'Rahilly et&#x000a0;al. <xref rid="joa12416-bib-0039" ref-type="ref">1987</xref>; Bullen &#x00026; Wilson, <xref rid="joa12416-bib-0007" ref-type="ref">1997</xref>) or by comparing foot and heel to knee length with a standard growth chart (Hern, <xref rid="joa12416-bib-0018" ref-type="ref">1984</xref>).</p></sec><sec id="joa12416-sec-0004"><title>Immunohistochemistry (IHC)</title><p>Brains were fixed in buffered 4% paraformaldehyde solution (PFA; Sigma Aldrich, Dorset, UK) and embedded in paraffin wax before sectioning. Deparaffinised coronal and sagittal sections collected on slides were immersed in 1.5% hydrogen peroxide&#x02005;:&#x02005;methanol solution (Sigma Aldrich) to block activity of endogenous peroxidases. Heat&#x02010;mediated antigen retrieval was carried out by treatment of sections in citrate buffer (pH&#x02005;6.0) before incubating sections with 10% of the appropriate normal serum (Vector Laboratories, Peterborough, UK) in Tris&#x02010;buffered saline (TBS) for 10&#x02005;min. For immunoperoxidase staining, sections were then incubated with a primary antibody (Tables&#x000a0;<xref rid="joa12416-tbl-0002" ref-type="table-wrap">2</xref> and <xref rid="joa12416-tbl-0003" ref-type="table-wrap">3</xref> for source of antibodies and dilutions used) in TBS solution overnight at 4&#x02005;&#x000b0;C. Sections were then washed and incubated for 30&#x02005;min with the appropriate biotinylated secondary antibody (Vector Laboratories), washed then incubated for 30&#x02005;min with Vectastain Elite ABC kit (Vector Laboratories) and developed using 3,3&#x02032;&#x02010;diaminobenzidine (Vector Laboratories). Sections were dehydrated, cleared and coverslipped.</p><table-wrap id="joa12416-tbl-0002" xml:lang="en" orientation="portrait" position="float"><label>Table 2</label><caption><p>Primary and secondary antibodies used in this study</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Primary antibody</th><th align="left" valign="top" rowspan="1" colspan="1">Species</th><th align="left" valign="top" rowspan="1" colspan="1">Dilution</th><th align="left" valign="top" rowspan="1" colspan="1">Supplier</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">KI67</td><td align="left" rowspan="1" colspan="1">Mouse</td><td align="left" rowspan="1" colspan="1">1/150</td><td align="left" rowspan="1" colspan="1">Dako, Cambridgeshire, UK, clone MIB1</td></tr><tr><td align="left" rowspan="1" colspan="1">NKX2.1</td><td align="left" rowspan="1" colspan="1">Mouse</td><td align="left" rowspan="1" colspan="1">1/150</td><td align="left" rowspan="1" colspan="1">Dako, Cambridgeshire, UK</td></tr><tr><td align="left" rowspan="1" colspan="1">PAX6</td><td align="left" rowspan="1" colspan="1">Rabbit polyclonal</td><td align="left" rowspan="1" colspan="1">1/1500</td><td align="left" rowspan="1" colspan="1">Covance, Cambridge Bioscience, UK</td></tr><tr><td align="left" rowspan="1" colspan="1">TBR1</td><td align="left" rowspan="1" colspan="1">Rabbit polyclonal</td><td align="left" rowspan="1" colspan="1">1/1500</td><td align="left" rowspan="1" colspan="1">Abcam, Cambridge, UK</td></tr><tr><td align="left" rowspan="1" colspan="1">TOP2A</td><td align="left" rowspan="1" colspan="1">Rabbit polyclonal</td><td align="left" rowspan="1" colspan="1">1/800</td><td align="left" rowspan="1" colspan="1">Prof. Caroline Austin<xref ref-type="fn" rid="joa12416-note-0002">a</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">TOP2B</td><td align="left" rowspan="1" colspan="1">Rabbit polyclonal</td><td align="left" rowspan="1" colspan="1">1/800</td><td align="left" rowspan="1" colspan="1">Prof. Caroline Austin<xref ref-type="fn" rid="joa12416-note-0002">a</xref>
</td></tr></tbody></table><table-wrap-foot><fn id="joa12416-note-0002"><label>a</label><p>From research funded by Leukaemia and Lymphoma Research.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><table-wrap id="joa12416-tbl-0003" xml:lang="en" orientation="portrait" position="float"><label>Table 3</label><caption><p>Immunogen sequences detected by polyclonal rabbit antibodies raised against TOP2A and TOP2B</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Gene</th><th align="left" valign="top" rowspan="1" colspan="1">Immunogen sequence</th><th align="left" valign="top" rowspan="1" colspan="1">Length/aa</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<bold>TOP2A</bold>
</td><td align="left" rowspan="1" colspan="1">EGSPQEDGVELEGLKQRLEKKQKREPGTKTKKQTTLAFKPIKKGKKRNPWSDSESDRSSDESNFDVPPRETEPRRAATKTKFTMDLDSDEDFSDFDEKTDDEDFVPSDASPPKTKTSPKLSNKELKPQKSVVSDLEADDVKGSVPLSSSPPATHFPDETEITNPVPKKNVTVKKTAAKSQSSTSTTGAKKRAAPKGTKRDPALNSGVSQKPDPAKTKNRRKRKPSTSDDSDSNFEKIVSKAVTSKKSKGESDDFHMDFDSAVAPRAKSVRAKKPIKYLEESDEDDLF</td><td align="char" char="." rowspan="1" colspan="1">287</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>TOP2B</bold>
</td><td align="left" rowspan="1" colspan="1">LDTAAVKVEFDEEFSGAPVEGAGEEALTPSVPINKGPKPKREKKEPGTRVRKTPTSSGKPSAKKVKKRNPWSDDESKSESDLEETEPVVIPRDSLLRRAAAERPKYTFDFSEEEDDDADDDDDDNNDLEELKVKASPITNDGEDEFVPSDGLDKDEYTFSPGKSKATPEKSLHDKKSQDFGNLFSFPSYSQKSEDDSAKFDSNEEDSASVFSPSFGLKQTDKVPSKTVAAKKGKPSSDTVPKPKRAPKQKKVVEAVNSDSDSEFGIPKKTTTPKGKGRGAKKRKASGSENEGDYNPGRKTSKTTSKKPKKTSFDQDSDVDIFPSDFPTEPPSLPRTGRARKEVKYFAESDEEEDDVDF</td><td align="char" char="." rowspan="1" colspan="1">358</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><p>For immunofluorescent double&#x02010;labelling, a novel procedure that allows two polyclonal primary antibodies to be employed was developed from the methods of Goto et&#x000a0;al. (<xref rid="joa12416-bib-0013" ref-type="ref">2015</xref>). Sections were incubated with the first primary antibody as before, washed and incubated with ImmPRESS&#x02122; HRP IgG (Peroxidase) Polymer Detection Kit, made in horse (IF; Vector Laboratories), washed then incubated for 30&#x02005;min with tyramide signal amplification (TSA&#x02122;) fluorescein plus system reagent (IF; Perkin Elmer, London, UK). After washing but before application of a second primary antibody, heat&#x02010;mediated antigen retrieval was carried out by treatment of sections in citrate buffer (pH&#x02005;6.0). This removes the first set of primary and secondary antibodies employed, but leaves fluorescent tyramide covalently bound to the tissue section. The method above was repeated for the detection of this second primary antibody, except that tyramide signal amplification (TSA&#x02122;) rhodamine plus was used for detection. Sections were then washed, stained with 4&#x02032;,6&#x02010;diamidino&#x02010;2&#x02010;phenylindole, dihydrochloride (DAPI; Thermo Fisher Scientific), washed and coverslipped with Vectashield (Vector Laboratories).</p></sec><sec id="joa12416-sec-0005"><title>Manufacture of <italic>in&#x000a0;situ</italic> hybridisation (ISH) probes</title><p>Polymerase chain reaction (PCR) using specific primers (Sigma Aldrich; Table&#x000a0;<xref rid="joa12416-tbl-0004" ref-type="table-wrap">4</xref>) amplified the required DNA fragment of the gene of interest using human brain foetal DNA as a template, which was run on a gel to confirm the correct size of the product. The band was gel extracted (Qiagen, Crawley, UK), and the DNA was cloned and transformed into competent cells using the pGEM<sup>&#x000ae;&#x02010;</sup>T Easy kit (Promega, Southampton, UK). Select colonies were grown in 5&#x02005;mL LB&#x02010;Broth (Invitrogen, Paisley, UK) with ampicillin (overnight). Plasmids were prepared using the Miniprep kit (Qiagen) and the HiSpeed plasmid Maxiprep kit (Qiagen) before restriction digest using the Qiagen PCR purification kit. Digoxigenin&#x02010;UTP was incorporated into riboprobes during <italic>in&#x000a0;vitro</italic> transcription using the DIG RNA Labelling Kit (SP6/T7; Roche, Indianapolis, USA) according to the manufacturer's instructions. Antisense and sense probes were generated using T7 and SP6 polymerase, respectively. Probe concentration was measured (Nanodrop; Thermo Scientific, Waltham, USA).</p><table-wrap id="joa12416-tbl-0004" xml:lang="en" orientation="portrait" position="float"><label>Table 4</label><caption><p>Primers used to manufacture probes used in the detection of TOP2A, TOP2B and TBR1 mRNA sequences</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Gene</th><th align="left" valign="top" rowspan="1" colspan="1">Forward primer 5&#x02032;&#x02013;3&#x02032; sequence</th><th align="left" valign="top" rowspan="1" colspan="1">Reverse primer 5&#x02032;&#x02013;3&#x02032; sequence</th><th align="center" valign="top" rowspan="1" colspan="1">Product size/bp</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">TBR1</td><td align="left" rowspan="1" colspan="1">TAAGTTAATACGACTCACTATAGGGCGA </td><td align="left" rowspan="1" colspan="1">AATACGATTTAGGTGACACTA TAGAATAC</td><td align="char" char="." rowspan="1" colspan="1">426</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">TOP2A</td><td align="left" rowspan="1" colspan="1">GCCCAAGACTGGTTTTAAAGTT</td><td align="left" rowspan="1" colspan="1">TGGAGATTTCCCAAAATGAATC</td><td align="char" char="." rowspan="1" colspan="1">800</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">TOP2B</td><td align="left" rowspan="1" colspan="1">TTGGTCAGATGATGAATCCAAG</td><td align="left" rowspan="1" colspan="1">AAGACGGTTTTCCCTTTTTAGC</td><td align="char" char="." rowspan="1" colspan="1">500</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap></sec><sec id="joa12416-sec-0006"><title>Tissue <italic>in&#x000a0;situ</italic> hybridisation (TISH)</title><p>Paraffin sections were dewaxed in two changes of histoclear and gradually hydrated in decreasing ethanol concentrations. Sections were washed twice in PBS fixed for 20&#x02005;min in PFA. Sections were washed twice in PBS and then incubated with proteinase K (20&#x02005;&#x003bc;L&#x000a0;mL<sup>&#x02212;1</sup>; Sigma Aldrich) for 8&#x02005;min and post&#x02010;fixed in 4% PFA&#x02005;:&#x02005;PBS (Sigma) at room temperature for 5&#x02005;min. After two washes in PBS, sections were treated with 0.1&#x02005;<sc>m</sc> tetraethylammonium/0.25% acetic anhydride for 10&#x02005;min, washed again twice in PBS. Dehydrated and air&#x02010;dried slides were covered with 300&#x02005;ng DIG&#x02010;labelled riboprobe, hybridisation mix (50% formamide, 0.3&#x02005;<sc>m</sc> NaCl, 20&#x02005;m<sc>m</sc> Tris pH&#x02005;8.5, 5&#x02005;m<sc>m</sc> EDTA pH&#x02005;8.0, 1&#x02005;&#x000d7;&#x02005;Denharts solution, 10% dextran sulphate), tRNA (0.5&#x02005;mg&#x000a0;mL<sup>&#x02212;1</sup>) and RNAse inhibitor (1&#x02005;&#x003bc;L&#x000a0;mL<sup>&#x02212;1</sup>), coverslipped and the mixture was incubated overnight at 65&#x02005;&#x000b0;C to allow hybridisation of probes to the tissue mRNA. Post&#x02010;hybridisation washes were performed [2&#x02005;&#x000d7;&#x02005;standard sodium citrate (SSC), 65&#x02005;&#x000b0;C; 0.2&#x02005;&#x000d7;&#x02005;SSC, 65&#x02005;&#x000b0;C; 2&#x02005;&#x000d7;&#x02005;formamide wash (350&#x02005;mL formamide, 70&#x02005;mL 20&#x02005;&#x000d7;&#x02005;SSC, 280&#x02005;mL dH<sub>2</sub>O)], and slides were incubated for 1&#x02005;h in 150&#x02005;m<sc>m</sc> NaCl and 100&#x02005;m<sc>m</sc> Tris&#x02013;HCl, pH&#x02005;7.5, containing 10% foetal calf serum followed by incubation with anti&#x02010;DIG&#x02005;:&#x02005;alkaline phosphatase and expression was visualised using NBT/BCIP (Roche), sections mounted using Vectamount (Vector Laboratories).</p></sec><sec id="joa12416-sec-0007"><title>Imaging</title><p>Images were taken using an Axioimager Z2 microscope equipped with an Axiocam and Axioimager Z2 4.8.1 software or scanned using the Leica SCN400 Slide Scanner. Final images for publication were produced using Adobe Photoshop CS6 software.</p></sec></sec><sec id="joa12416-sec-0008"><title>Results</title><sec id="joa12416-sec-0009"><title>TOP2A is expressed in regions of cell division</title><p>TOP2A protein localisation was determined using antibodies that recognise the C&#x02010;terminal domain of the protein (Fig.&#x000a0;<xref rid="joa12416-fig-0001" ref-type="fig">1</xref>A), residues 1244&#x02013;1531 (Table&#x000a0;<xref rid="joa12416-tbl-0002" ref-type="table-wrap">2</xref>). The transcription factor PAX6 is involved in cortico&#x02010;neurogenesis and expressed in the radial glial progenitor cells found in the VZ and SVZ of the developing human cerebral cortex (Bayatti et&#x000a0;al. <xref rid="joa12416-bib-0003" ref-type="ref">2008a</xref>,<xref rid="joa12416-bib-0004" ref-type="ref">b</xref>; Lui et&#x000a0;al. <xref rid="joa12416-bib-0029" ref-type="ref">2011</xref>; Fig.&#x000a0;<xref rid="joa12416-fig-0002" ref-type="fig">2</xref>). TOP2A immunoreactivity was detected in these proliferative regions at 9, 11 and 12&#x02005;PCW (Fig.&#x000a0;<xref rid="joa12416-fig-0002" ref-type="fig">2</xref>), although fewer cells were TOP2A&#x02010;positive than PAX6&#x02010;positive, suggesting that TOP2A protein is not found in all radial glial progenitor cells. Instead, the staining was more comparable to that of the marker of cell division KI67 (Scholzen &#x00026; Gerdes, <xref rid="joa12416-bib-0044" ref-type="ref">2000</xref>; Fig.&#x000a0;<xref rid="joa12416-fig-0002" ref-type="fig">2</xref>). TOP2A and KI67 both appeared very strongly at the apical surface of the VZ (Fig.&#x000a0;<xref rid="joa12416-fig-0002" ref-type="fig">2</xref>), where cells are in the G2/M phase of division (Scholzen &#x00026; Gerdes, <xref rid="joa12416-bib-0044" ref-type="ref">2000</xref>). Both markers also densely labelled cells in the inner subventricular zone (ISVZ; Fig.&#x000a0;<xref rid="joa12416-fig-0002" ref-type="fig">2</xref>), where TBR2&#x02010;expressing intermediate progenitor cells are located (Bayatti et&#x000a0;al. <xref rid="joa12416-bib-0003" ref-type="ref">2008a</xref>; Lui et&#x000a0;al. <xref rid="joa12416-bib-0029" ref-type="ref">2011</xref>). A few cells of the intermediate zone (IZ) also stained positively for TOP2A at 9&#x02005;PCW; however, as the IZ expands and becomes a more prominent feature of the cerebral cortex, fewer TOP2A&#x02010;immunopositive cells could be found (Fig.&#x000a0;<xref rid="joa12416-fig-0002" ref-type="fig">2</xref>). The proliferative VZ and SVZ decreased in relative size as the cortex aged from 9 to 12&#x02005;PCW due to the expansion of the post&#x02010;mitotic layers.</p><fig fig-type="Figure" xml:lang="en" id="joa12416-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Schematic of <styled-content style="fixed-case">TOP</styled-content>2A and B protein and <styled-content style="fixed-case">mRNA</styled-content> showing the regions detected/amplified by IHC and ISH techniques. Polyclonal antibodies designed to recognise the C&#x02010;terminal domain of the <styled-content style="fixed-case">TOP</styled-content>2A and <styled-content style="fixed-case">TOP</styled-content>2B proteins were designed (A). Probes were manufactured to identify the 3&#x02032; <styled-content style="fixed-case">UTR</styled-content> of <styled-content style="fixed-case">TOP</styled-content>2A within exon 34 and a region spanning exons 30&#x02013;34 near the end of the coding sequence for <styled-content style="fixed-case">TOP</styled-content>2B (B). Control probes were designed for the same regions to identify any antisense transcripts or non&#x02010;specific staining.</p></caption><graphic id="nlm-graphic-1" xlink:href="JOA-228-452-g001"/></fig><fig fig-type="Figure" xml:lang="en" id="joa12416-fig-0002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Immunoperoxidase staining for <styled-content style="fixed-case">TOP</styled-content>2A and <styled-content style="fixed-case">TOP</styled-content>2B in the human cerebral cortex. <styled-content style="fixed-case">PAX</styled-content>6 transcription factor immunoreactivity identified the ventricular zone (<styled-content style="fixed-case">VZ</styled-content>) and subventricular zone (<styled-content style="fixed-case">SVZ</styled-content>) of the human cerebral cortex from 9 to 12&#x02005;<styled-content style="fixed-case">PCW</styled-content>. <styled-content style="fixed-case">TOP</styled-content>2A immunoreactivity was confined to the proliferative ventricular and subventricular regions at 9, 11 and 12&#x02005;<styled-content style="fixed-case">PCW</styled-content> (A&#x02013;C), and was similar in distribution to immunoreactivity for the cell division marker, <styled-content style="fixed-case">KI</styled-content>67. Both were more prevalent in the inner than outer subventricular zone (<styled-content style="fixed-case">ISVZ</styled-content> and <styled-content style="fixed-case">OSVZ</styled-content>) that emerge by 11&#x02005;<styled-content style="fixed-case">PCW</styled-content>, unlike <styled-content style="fixed-case">PAX</styled-content>6, which is unformly expressed throughout the <styled-content style="fixed-case">SVZ</styled-content>. From 9 to 12&#x02005;<styled-content style="fixed-case">PCW</styled-content>,<styled-content style="fixed-case"> TOP</styled-content>2B immunoreactivity was present in the <styled-content style="fixed-case">VZ</styled-content> and <styled-content style="fixed-case">SVZ</styled-content>, as well as the intermediate zone (<styled-content style="fixed-case">IZ</styled-content>), subplate (<styled-content style="fixed-case">SP</styled-content>), post&#x02010;mitotic cortical plate (<styled-content style="fixed-case">CP</styled-content>) and cell sparse marginal zone (<styled-content style="fixed-case">MZ</styled-content>), all of which were also immunopositive for the transcription factor <styled-content style="fixed-case">TBR</styled-content>1 (A&#x02013;C). Scale bar:&#x000a0;250&#x02005;&#x003bc;m.</p></caption><graphic id="nlm-graphic-3" xlink:href="JOA-228-452-g002"/></fig><p>To explore the extent of co&#x02010;localisation more precisely, double&#x02010;label immunofluorescence was attempted with a novel method that allowed the use of two primary antibodies from the same species and gave more sensitivity with paraffin sections than using conventional fluorescently conjugated secondary antibodies. It was possible to demonstrate that TOP2A was indeed co&#x02010;expressed with Ki&#x02010;67 (Fig.&#x000a0;<xref rid="joa12416-fig-0003" ref-type="fig">3</xref>A), whereas not all PAX6&#x02010;positive radial glial cells were TOP2A&#x02010;positive (Fig.&#x000a0;<xref rid="joa12416-fig-0003" ref-type="fig">3</xref>C), only those found at locations where KI67 was expressed, principally the apical surface of the VZ, and the ISVZ. As predicted, cells that express the post&#x02010;mitotic marker TBR1 did not express TOP2A (Fig.&#x000a0;<xref rid="joa12416-fig-0003" ref-type="fig">3</xref>E). TBR1 expression was restricted to the CP, IZ and some cells of the SVZ. TBR1 was not expressed in the VZ and cells that expressed TBR1 in the SVZ did not co&#x02010;express TOP2A.</p><fig fig-type="Figure" xml:lang="en" id="joa12416-fig-0003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Immunofluorescent double&#x02010;labelling for <styled-content style="fixed-case">TOP</styled-content>2A,<styled-content style="fixed-case">TOP</styled-content>2B and other markers in the human cerebral cortex. (A&#x02013;E) Taken from an 11&#x02005;<styled-content style="fixed-case">PCW</styled-content> foetus, (F, G) from 12&#x02005;<styled-content style="fixed-case">PCW</styled-content>. (A) Extensive co&#x02010;expression (pale green, yellow and orange cells) of <styled-content style="fixed-case">TOP</styled-content>2A (red) and <styled-content style="fixed-case">KI</styled-content>67 (green) immunofluorescence, whereas (B) demonstrates that there was very little co&#x02010;expression of <styled-content style="fixed-case">TOP</styled-content>2B and <styled-content style="fixed-case">KI</styled-content>67 as red and green cells predominate. (C) Not all <styled-content style="fixed-case">PAX</styled-content>6&#x02010;expressing cells co&#x02010;expressed <styled-content style="fixed-case">TOP</styled-content>2A, but those that did clustered close to the apical surface of the ventricular zone (<styled-content style="fixed-case">VZ</styled-content>) and the border of the ventricular and subventricular zones (white arrows). Cells co&#x02010;expressing <styled-content style="fixed-case">TOP</styled-content>2A and <styled-content style="fixed-case">TOP</styled-content>2B also preferred these locations (D). (E) <styled-content style="fixed-case">TOP</styled-content>2A and <styled-content style="fixed-case">TBR</styled-content>1 show separation of expression although with a mingling of cells in the <styled-content style="fixed-case">SVZ</styled-content>. On the other hand, (F) shows that <styled-content style="fixed-case">TBR</styled-content>1 was co&#x02010;expressed with <styled-content style="fixed-case">TOP</styled-content>2B in many cells in the cortical plate (<styled-content style="fixed-case">CP</styled-content>), intermediate zone (<styled-content style="fixed-case">IZ</styled-content>) and subventricular zone (SVZ; G), although cells expressing only <styled-content style="fixed-case">TOP</styled-content>2A were observed throughout the <styled-content style="fixed-case">CP</styled-content> and cells expressing <styled-content style="fixed-case">TBR</styled-content>1 only were frequently seen in the deeper layers of the <styled-content style="fixed-case">CP</styled-content>, marginal zone (<styled-content style="fixed-case">MZ</styled-content>) and subplate (<styled-content style="fixed-case">SP</styled-content>). Scale bars:&#x000a0;100&#x02005;&#x003bc;m (in A for A&#x02013;D, E, and in F for F and G).</p></caption><graphic id="nlm-graphic-5" xlink:href="JOA-228-452-g003"/></fig></sec><sec id="joa12416-sec-0010"><title>TOP2B is expressed in both proliferative and post&#x02010;mitotic regions of the cortex</title><p>TOP2B protein localisation was determined using antibodies that recognise the C&#x02010;terminal domain of the protein (Fig.&#x000a0;<xref rid="joa12416-fig-0001" ref-type="fig">1</xref>A), residues 1263&#x02013;1621 (Table&#x000a0;<xref rid="joa12416-tbl-0001" ref-type="table-wrap">1</xref>). TOP2B, in contrast to TOP2A, was observed throughout the cortex in layers occupied by both PAX6&#x02010;positive proliferative radial glia and TBR1&#x02010;positive post&#x02010;mitotic neurons (Englund et&#x000a0;al. <xref rid="joa12416-bib-0011" ref-type="ref">2005</xref>; Bedogni et&#x000a0;al. <xref rid="joa12416-bib-0005" ref-type="ref">2010</xref>; Fig.&#x000a0;<xref rid="joa12416-fig-0002" ref-type="fig">2</xref>). At 9&#x02005;PCW, TOP2B immunostaining was stronger in the SVZ and the CP than in the VZ, as was the case for TBR1 immunoreactivity (Fig.&#x000a0;<xref rid="joa12416-fig-0002" ref-type="fig">2</xref>). At 9&#x02005;PCW, the ventricular surface was immunopositive for TOP2B (Fig.&#x000a0;<xref rid="joa12416-fig-0002" ref-type="fig">2</xref>) as it was for TOP2A, suggesting again that cells in the G2/M phase of cell division might express TOP2B as well as TOP2A. This is as expected as both TOP2B and TOP2A are expressed in undifferentiated cells (Thakurela et&#x000a0;al. <xref rid="joa12416-bib-0048" ref-type="ref">2013</xref>). By 11&#x02005;PCW (Fig.&#x000a0;<xref rid="joa12416-fig-0002" ref-type="fig">2</xref>), staining was uniform throughout the VZ and was no longer stronger at the ventricular surface. Double&#x02010;labelling at 11&#x02005;PCW showed that cells expressing KI67 did not express TOP2B (Fig.&#x000a0;<xref rid="joa12416-fig-0003" ref-type="fig">3</xref>B). TOP2B was expressed in cells throughout the VZ and SVZ; however, these cells were not KI67&#x02010;positive. In comparison to this, some of the cells at the apical VZ and inner SVZ did express both TOP2A and TOP2B (Fig.&#x000a0;<xref rid="joa12416-fig-0003" ref-type="fig">3</xref>D). This showed that not all of the cells expressing KI67 were immunopositive for TOP2A. Instead, there was a small proportion of TOP2A cells that may have ceased to express KI67 and have begun to co&#x02010;express TOP2A and TOP2B.</p><p>TBR1 expression was restricted to the CP, IZ and some cells of the SVZ. TBR1 was not expressed in the VZ and cells that express TBR1 in the SVZ did not co&#x02010;express TOP2A (Fig.&#x000a0;<xref rid="joa12416-fig-0003" ref-type="fig">3</xref>E). Although devoid of TOP2A expression, the post&#x02010;mitotic CP was immunopositive for TOP2B from 9 to 12&#x02005;PCW. Cells in this region have ceased division and have begun to differentiate into neurons. Fluorescent double&#x02010;labelling using TBR1 and TOP2B (Fig.&#x000a0;<xref rid="joa12416-fig-0003" ref-type="fig">3</xref>F) confirmed that cells of the CP and IZ co&#x02010;expressed these markers. A closer look at the cells of the CP reveals that cells that co&#x02010;express both TBR1 and TOP2B were concentrated in the outer layers of the CP where younger cells have just finished radial migration from the proliferative zones (Rakic, <xref rid="joa12416-bib-0043" ref-type="ref">2009</xref>), whereas layers that contain the most mature neurons, the inner layer of the CP, as well as the SP and MZ, contained many cells that were only TBR1&#x02010;positive (Fig.&#x000a0;<xref rid="joa12416-fig-0003" ref-type="fig">3</xref>F). Only a limited number of cells in this region were both TBR1 and TOP2B immunofluorescent. The majority of cells in the IZ expressed both TBR1 and TOP2B, and these may be radially migrating neuroblasts (Fig.&#x000a0;<xref rid="joa12416-fig-0003" ref-type="fig">3</xref>F). A proportion of cells in the CP only expressed TOP2B, and these may be interneurons that do not express TBR1 as they are born in the GE (Hansen et&#x000a0;al. <xref rid="joa12416-bib-0016" ref-type="ref">2013</xref>) but do express TOP2B (see below) and migrate tangentially to the CP (Hansen et&#x000a0;al. <xref rid="joa12416-bib-0016" ref-type="ref">2013</xref>). There were a limited number of cells within the IZ and SVZ that expressed only TOP2B as is the case in the cells of the VZ (Fig.&#x000a0;<xref rid="joa12416-fig-0003" ref-type="fig">3</xref>G). The presence of TOP2B and not TOP2A in the CP suggests a separate role for TOP2B in the post&#x02010;mitotic cortical cells of the developing cerebral cortex; however, TOP2B appears to be downregulated as the neurons mature.</p></sec><sec id="joa12416-sec-0011"><title>TOP2A is more prominent in the MGE than in the lateral ganglionic eminence (LGE)</title><p>The cells of the GE can be split into distinct populations known as the LGE, MGE and caudal ganglionic eminence regions, all of which contain a high proportion of proliferative cells (Del Bigio, <xref rid="joa12416-bib-0010" ref-type="ref">2011</xref>). The location of the MGE was revealed by NKX2.1 immunoreactivity (Fig.&#x000a0;<xref rid="joa12416-fig-0004" ref-type="fig">4</xref>A), whilst PAX6 immunoreactivity extended from the proliferative zones of the ventral pallium of the cortex into the LGE (Fig.&#x000a0;<xref rid="joa12416-fig-0004" ref-type="fig">4</xref>B) but decreased in expression in a lateral to medial gradient. Both KI67 (Fig.&#x000a0;<xref rid="joa12416-fig-0004" ref-type="fig">4</xref>C) and TOP2A (Fig.&#x000a0;<xref rid="joa12416-fig-0004" ref-type="fig">4</xref>D) immunoreactivity were observed in the MGE and LGE; however, the immunoreactivity was less dense at the LGE&#x02005;:&#x02005;MGE boundary (arrowhead) compared with the density of cells shown by the H&#x00026;E stain (Fig.&#x000a0;<xref rid="joa12416-fig-0005" ref-type="fig">5</xref>). TOP2B immunoreactivity was observed throughout the MGE and LGE with no boundary apparent (Fig.&#x000a0;<xref rid="joa12416-fig-0004" ref-type="fig">4</xref>E). TOP2A immunopositivity appeared to be stronger in the MGE (Fig.&#x000a0;<xref rid="joa12416-fig-0004" ref-type="fig">4</xref>D) in comparison to TOP2B, which appeared to be stronger in the LGE (Fig.&#x000a0;<xref rid="joa12416-fig-0004" ref-type="fig">4</xref>E). The emerging caudate nucleus, which contains post&#x02010;mitotic cells migrating away from the proliferative zones of the GE, showed high levels of TOP2B expression, but not TOP2A expression (Fig.&#x000a0;<xref rid="joa12416-fig-0004" ref-type="fig">4</xref>D,E).</p><fig fig-type="Figure" xml:lang="en" id="joa12416-fig-0004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>
<styled-content style="fixed-case">TOP</styled-content>2A and TOP2B immunoreactivity in the ganglionic eminences (<styled-content style="fixed-case">GE</styled-content>). <styled-content style="fixed-case">NKX</styled-content>2.1 immunopositivity (A) was predominantly observed in the medial ganglionic eminence (<styled-content style="fixed-case">MGE</styled-content>), whilst <styled-content style="fixed-case">PAX</styled-content>6 immunoreactivity (B) marked the lateral ganglionic eminence (LGE). The dividing cells in both the <styled-content style="fixed-case">MGE</styled-content> and <styled-content style="fixed-case">LGE</styled-content> were immunopositive for <styled-content style="fixed-case">KI</styled-content>67 (C), <styled-content style="fixed-case">TOP</styled-content>2A (D) and <styled-content style="fixed-case">TOP</styled-content>2B (E). The medial part of the <styled-content style="fixed-case">LGE</styled-content> showed a reduction in <styled-content style="fixed-case">KI</styled-content>67, <styled-content style="fixed-case">PAX</styled-content>6 and <styled-content style="fixed-case">TOP</styled-content>2A immunoreactivity. <styled-content style="fixed-case">TOP</styled-content>2B immunopositivity was also observed in the caudate and putamen (E), whereas <styled-content style="fixed-case">TOP</styled-content>2A was absent from these post&#x02010;mitotic regions (D). (D and E) contain high&#x02010;magnification views of the transition between proliferative and post&#x02010;mitotic cell layers. Scale bar:&#x000a0;1&#x02005;mm in low&#x02010;magnification images; 75&#x02005;&#x003bc;m in high&#x02010;magnification insets.</p></caption><graphic id="nlm-graphic-7" xlink:href="JOA-228-452-g004"/></fig><fig fig-type="Figure" xml:lang="en" id="joa12416-fig-0005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Haematoxylin and eosin (H&#x00026;E) staining of a coronal section through the human telencephalon at 12&#x02005;<styled-content style="fixed-case">PCW</styled-content>. The ventricular zone (<styled-content style="fixed-case">VZ</styled-content>) and subventricular zone (<styled-content style="fixed-case">SVZ</styled-content>) of the cerebral cortex and the lateral and medial ganglionic eminences (<styled-content style="fixed-case">LGE</styled-content> and <styled-content style="fixed-case">MGE</styled-content>) contain proliferative cells. In the cortex, cells migrate from the <styled-content style="fixed-case">VZ</styled-content> and <styled-content style="fixed-case">SVZ</styled-content>, through the intermediate zone (<styled-content style="fixed-case">IZ</styled-content>), to reach the post&#x02010;mitotic cortical plate (<styled-content style="fixed-case">CP</styled-content>). The caudate, putamen and globus pallidus are regions containing post&#x02010;mitotic cells derived from the ganglionic eminences (GE). Scale bar:&#x000a0;1&#x02005;mm in low&#x02010;magnification image; 200&#x02005;&#x003bc;m in high&#x02010;magnification insert.</p></caption><graphic id="nlm-graphic-9" xlink:href="JOA-228-452-g005"/></fig></sec><sec id="joa12416-sec-0012"><title>
<italic>TOP2A</italic> and <italic>TOP2B</italic> mRNA expressed at the apical surface of the VZ, and <italic>TOP2B</italic> expressed throughout the cortex</title><p>At 12&#x02005;PCW, <italic>TBR1</italic> mRNA was located in the post&#x02010;mitotic cells of the CP (Fig.&#x000a0;<xref rid="joa12416-fig-0006" ref-type="fig">6</xref>A). This corresponded with TBR1 protein localisation (Figs&#x000a0;<xref rid="joa12416-fig-0002" ref-type="fig">2</xref> and <xref rid="joa12416-fig-0003" ref-type="fig">3</xref>). <italic>TOP2A</italic> mRNA was restricted to the apical surface of the VZ as well as a small number of cells scattered throughout the VZ (Fig.&#x000a0;<xref rid="joa12416-fig-0006" ref-type="fig">6</xref>C). This differed slightly from TOP2A protein localisation as the protein was found throughout the VZ and SVZ (Fig.&#x000a0;<xref rid="joa12416-fig-0002" ref-type="fig">2</xref>). This suggests that <italic>TOP2A</italic> mRNA has a much shorter half&#x02010;life than the protein and that its expression is tightly controlled. <italic>TOP2B</italic> mRNA was detected throughout the cortex at 12&#x02005;PCW in both proliferative and post&#x02010;mitotic regions (Fig.&#x000a0;<xref rid="joa12416-fig-0006" ref-type="fig">6</xref>E). This matched the protein expression of TOP2B (Fig.&#x000a0;<xref rid="joa12416-fig-0002" ref-type="fig">2</xref>).</p><fig fig-type="Figure" xml:lang="en" id="joa12416-fig-0006" orientation="portrait" position="float"><label>Figure 6</label><caption><p>
<styled-content style="fixed-case">TOP</styled-content>2A and <styled-content style="fixed-case">TOP</styled-content>2B <styled-content style="fixed-case">mRNA</styled-content> expression in the cortex at 12&#x02005;<styled-content style="fixed-case">PCW</styled-content>. <styled-content style="fixed-case">TBR</styled-content>1 <styled-content style="fixed-case">mRNA</styled-content> was detected in the cortical plate (<styled-content style="fixed-case">CP</styled-content>) of the cerebral cortex at 12&#x02005;<styled-content style="fixed-case">PCW</styled-content>, and was absent from the intermediate zone (<styled-content style="fixed-case">IZ</styled-content>) and ventricular zone (<styled-content style="fixed-case">VZ</styled-content>) (A). <styled-content style="fixed-case">TOP</styled-content>2A <styled-content style="fixed-case">mRNA</styled-content> was detected at the apical surface of the <styled-content style="fixed-case">VZ</styled-content> (C) and in a small proportion of cells scattered throughout the <styled-content style="fixed-case">VZ</styled-content> (C). <styled-content style="fixed-case">TOP</styled-content>2B <styled-content style="fixed-case">mRNA</styled-content> was detected throughout the cortex in both the proliferative <styled-content style="fixed-case">VZ</styled-content> and subventricular zone (<styled-content style="fixed-case">SVZ</styled-content>), the <styled-content style="fixed-case">IZ</styled-content> and the post&#x02010;mitotic <styled-content style="fixed-case">CP</styled-content> (E). Control experiments with sense transcripts to <styled-content style="fixed-case">TBR</styled-content>1 (B), <styled-content style="fixed-case">TOP</styled-content>2A (D) and <styled-content style="fixed-case">TOP</styled-content>2B (F) showed no staining of the cortex at 12&#x02005;<styled-content style="fixed-case">PCW</styled-content>. Scale bar:&#x000a0;250&#x02005;&#x003bc;m.</p></caption><graphic id="nlm-graphic-11" xlink:href="JOA-228-452-g006"/></fig></sec></sec><sec id="joa12416-sec-0013"><title>Discussion</title><p>It was found that TOP2A and TOP2B mRNA and protein are expressed in the VZ and SVZ of both the pallium and subpallium of the human telencephalon between 9 and 12&#x02005;PCW. In addition, TOP2B was also expressed in post&#x02010;mitotic cells of the telencephalon, suggesting it may have a role in transcription in immature human neurons.</p><sec id="joa12416-sec-0014"><title>Expression in the proliferative zones of the pallium</title><p>The precise localisation of TOP2A expression and the differences between protein and mRNA give clues to the nature of cell proliferation in human pallial proliferative zones. Far fewer cells expressed TOP2A than PAX6, the marker for radial glial progenitors, which is the major population of progenitor cells at this stage of primate cortical development (Lui et&#x000a0;al. <xref rid="joa12416-bib-0029" ref-type="ref">2011</xref>; Betizeau et&#x000a0;al. <xref rid="joa12416-bib-0006" ref-type="ref">2013</xref>). However, the majority of cells that express TOP2A also express KI67, the&#x000a0;cell division marker that is expressed throughout all the&#x000a0;phases of the cell cycle (Scholzen &#x00026; Gerdes, <xref rid="joa12416-bib-0044" ref-type="ref">2000</xref>).</p><p>
<italic>TOP2A</italic> mRNA was, however, more restricted in expression, suggesting that its half&#x02010;life is much less than the protein and is restricted to the G2/M phase, as it is seen predominantly in cells near to the apical surface of the VZ. During asymmetric division of apical radial glial cells, the nucleus undergoes interkinetic nuclear migration, shuttling between the basal boundary of the VZ and the apical (ventricular) surface in phase with the cell cycle, and is critical for self&#x02010;renewal of neural progenitor cells (Kosodo et&#x000a0;al. <xref rid="joa12416-bib-0027" ref-type="ref">2004</xref>; Taverna &#x00026; Huttner, <xref rid="joa12416-bib-0047" ref-type="ref">2010</xref>). TOP2A expression is known to increase throughout the S phase and peak during the G2/M phase, before being rapidly degraded during G1 (Heck et&#x000a0;al. <xref rid="joa12416-bib-0017" ref-type="ref">1988</xref>; Woessner et&#x000a0;al. <xref rid="joa12416-bib-0054" ref-type="ref">1991</xref>; Negri et&#x000a0;al. <xref rid="joa12416-bib-0034" ref-type="ref">1992</xref>). Interestingly, although TOP2A and KI67 immunoreactiv&#x02010;ity were observed in the SVZ, and likely to be localised to dividing basal radial glia and intermediate progenitor cells (Lui et&#x000a0;al. <xref rid="joa12416-bib-0029" ref-type="ref">2011</xref>; Betizeau et&#x000a0;al. <xref rid="joa12416-bib-0006" ref-type="ref">2013</xref>), very little <italic>TOP2A</italic> mRNA expression was seen in this compartment. Perhaps cell division occurs less frequently in the SVZ or, alternatively, this reflects a difference in the dynamics of cell division once progenitors lose their apical process and cease to undergo interkinetic nuclear migration (Taverna &#x00026; Huttner, <xref rid="joa12416-bib-0047" ref-type="ref">2010</xref>).</p><p>Cells of the VZ and SVZ showed either KI67 or TOP2B expression, suggesting that TOP2B is not involved in cell division. TOP2B also appears to be redundant during this process in human cell lines (Grue et&#x000a0;al. <xref rid="joa12416-bib-0014" ref-type="ref">1998</xref>) and neurogenesis is normal in Top2b knockout mice (Yang et&#x000a0;al. <xref rid="joa12416-bib-0058" ref-type="ref">2000</xref>). There are, however, cells that co&#x02010;express TOP2A and TOP2B in these proliferative regions suggesting that, as cells begin to differentiate, there is an overlap in type II topoisomerase expression during the transition from DNA replication to RNA transcription. <italic>Top2b</italic> is expressed by post&#x02010;mitotic neurons (Capranico et&#x000a0;al. <xref rid="joa12416-bib-0008" ref-type="ref">1992</xref>; Tsutsui et&#x000a0;al. <xref rid="joa12416-bib-0050" ref-type="ref">1993</xref>; Tiwari et&#x000a0;al. <xref rid="joa12416-bib-0049" ref-type="ref">2012</xref>). Co&#x02010;expression of TOP2B with the post&#x02010;mitotic marker TBR1 in the human SVZ has been demonstrated. It is known that many cells in the human SVZ express several post&#x02010;mitotic neuronal markers, such as TBR1, MAP2 and CTIP2 (Bayatti et&#x000a0;al. <xref rid="joa12416-bib-0003" ref-type="ref">2008a</xref>; Ip et&#x000a0;al. <xref rid="joa12416-bib-0021" ref-type="ref">2011</xref>), and therefore the increased expression of TOP2B in the SVZ may reflect this.</p></sec><sec id="joa12416-sec-0015"><title>Expression in the subpallium</title><p>A complicated pattern of expression of TOP2A was observed across the subpallial compartments, but this most likely matches the extent to which cell division is taking place at each location, as it matches the pattern of KI67 expression. Reduced TOP2A expression at the medial boundary of the LGE coincides with a reduced density of dividing cells and PAX6&#x02010;positive radial glia. However, this does not prove a requirement for PAX6&#x02010;expressing radial glia in order to observe dividing cells as TOP2A expression is high in the MGE in the absence of PAX6. The MGE is the developmental source of pallidal projection neurons, striatal interneurons and about 50% of cortical inhibitory interneurons in the human (Marin et&#x000a0;al. <xref rid="joa12416-bib-0031" ref-type="ref">2000</xref>; Xu et&#x000a0;al. <xref rid="joa12416-bib-0055" ref-type="ref">2008</xref>; Hernandez&#x02010;Miranda et&#x000a0;al. <xref rid="joa12416-bib-0019" ref-type="ref">2010</xref>; Hansen et&#x000a0;al. <xref rid="joa12416-bib-0016" ref-type="ref">2013</xref>; Wang et&#x000a0;al. <xref rid="joa12416-bib-0052" ref-type="ref">2013</xref>). Neural stem cells (VZ) and intermediate progenitors (SVZ) of the MGE instead express NKX2.1, and the SVZ of the MGE is expanded in size and complexity in primate compared with the rodent, presumably to provide increased numbers of interneurons to populate the relative larger cerebral cortex of primate species (Hansen et&#x000a0;al. <xref rid="joa12416-bib-0016" ref-type="ref">2013</xref>). The high levels of TOP2A expression in this compartment may reflect this increased level of cortical interneuron progenitor activity.</p></sec><sec id="joa12416-sec-0016"><title>TOP2B expression in post&#x02010;mitotic neurons</title><p>As in rodents, TOP2B mRNA and protein is found in the post&#x02010;mitotic CP where no DNA synthesis is taking place, consistent with the suggestion that it regulates gene expression concerned with cell differentiation and survival (Thakurela et&#x000a0;al. <xref rid="joa12416-bib-0048" ref-type="ref">2013</xref>). Cells that co&#x02010;express TOP2B and TBR1 are more apparent in the superficial layers of the CP, which are formed from the cells that have most recently migrated here from the proliferative regions, past the deep layer neurons (Rakic, <xref rid="joa12416-bib-0043" ref-type="ref">2009</xref>). This suggests that cells may lose TOP2B expression as they mature. At later stages of mouse development, both TOP2A and TOP2B expression in the brain decreases (Capranico et&#x000a0;al. <xref rid="joa12416-bib-0008" ref-type="ref">1992</xref>).</p><p>Top2b knockdown is known to disrupt target finding of axons (Yang et&#x000a0;al. <xref rid="joa12416-bib-0058" ref-type="ref">2000</xref>), and produce shorter neurite lengths and growth cone degeneration (Nur&#x02010;E&#x02010;Kamal et&#x000a0;al. <xref rid="joa12416-bib-0038" ref-type="ref">2007</xref>). Top2b has been proposed as the main regulator of ganglion cell axon path&#x02010;finding during zebrafish retinal development (Nevin et&#x000a0;al. <xref rid="joa12416-bib-0035" ref-type="ref">2011</xref>). Mouse retina&#x02010;specific Top2b knockout alters expression of a number of genes concerned with both cell survival and differentiation, and results in aberrant lamination of the retina as well as loss of synaptic connections in the inner and outer plexiform layers, and the degeneration of neurofilaments. Interestingly, neurexin genes 1 and 3, which code for cell adhesion molecules implicated in synapse formation and stabilisation, are significantly downregulated (Li et&#x000a0;al. <xref rid="joa12416-bib-0028" ref-type="ref">2014</xref>). These genes have been identified as risk alleles for ASDs in human (Feng et&#x000a0;al. <xref rid="joa12416-bib-0012" ref-type="ref">2006</xref>; Szatmari et&#x000a0;al. <xref rid="joa12416-bib-0045" ref-type="ref">2007</xref>; Yan et&#x000a0;al. <xref rid="joa12416-bib-0057" ref-type="ref">2008</xref>; Vaags et&#x000a0;al. <xref rid="joa12416-bib-0051" ref-type="ref">2012</xref>; Dachtler et&#x000a0;al. <xref rid="joa12416-bib-0009" ref-type="ref">2014</xref>). Inhibition or knockdown of Top2b in cultured murine neurons decreased the expression of a very similar set of genes greater than 67&#x02005;kb in size many of which, in humans, are susceptibility genes for ASD and involved in synaptic adhesion and synapse formation, including NRXNs 1 and 3 (King et&#x000a0;al. <xref rid="joa12416-bib-0025" ref-type="ref">2013</xref>). These NRXNS, along with other susceptibility genes such as CNTNAP2 and RELN included in the gene set, are known from microarray, qPCR, RNAseq and histological studies to be expressed in post&#x02010;mitotic compartments of the early human foetal cortex (Meyer et&#x000a0;al. <xref rid="joa12416-bib-0033" ref-type="ref">2000</xref>; Abrahams et&#x000a0;al. <xref rid="joa12416-bib-0001" ref-type="ref">2007</xref>; Ip et&#x000a0;al. <xref rid="joa12416-bib-0020" ref-type="ref">2010</xref>; Kang et&#x000a0;al. <xref rid="joa12416-bib-0024" ref-type="ref">2011</xref>; Konopka et&#x000a0;al. <xref rid="joa12416-bib-0026" ref-type="ref">2012</xref>), suggesting ASD susceptibility genes may have roles in early developmental events such as cell migration and axon outgrowth, as well as late events such as synapse formation and stabilisation.</p></sec></sec></body><back><ack id="joa12416-sec-0017"><title>Acknowledgements</title><p>The human embryonic and foetal material was provided by the (Joint MRC)/Wellcome Trust (grant # 099175/Z/12/Z) Human Developmental Biology Resource (<ext-link ext-link-type="uri" xlink:href="http://www.hdbr.org">www.hdbr.org</ext-link>). Lauren Harkin is in receipt of an Anatomical Society of Great Britain and Ireland Post&#x02010;Graduate Studentship. The authors are grateful to Ms Fareha Khalil for assistance with the NKX2.1 immunohistochemistry, Dr Steven Lisgo for his help with the transportation and scanning of human material, and to Prof. Susan Lindsay for her advice and support.</p></ack><ref-list content-type="cited-references" id="joa12416-bibl-0001"><title>References</title><ref id="joa12416-bib-0001"><mixed-citation publication-type="journal" id="joa12416-cit-0001">
<string-name>
<surname>Abrahams</surname>
<given-names>BS</given-names>
</string-name>, <string-name>
<surname>Tentler</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Perederiy</surname>
<given-names>JV</given-names>
</string-name>, et&#x000a0;al. (<year>2007</year>) <article-title>Genome&#x02010;wide analyses of human perisylvian cerebral cortical patterning</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>104</volume>, <fpage>17&#x02005;849</fpage>&#x02013;<lpage>17&#x02005;854</lpage>.</mixed-citation></ref><ref id="joa12416-bib-0002"><mixed-citation publication-type="journal" id="joa12416-cit-0002">
<string-name>
<surname>Austin</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Marsh</surname>
<given-names>KL</given-names>
</string-name> (<year>1998</year>) <article-title>Eukaryotic DNA topoisomerase II beta</article-title>. <source>BioEssays</source>
<volume>20</volume>, <fpage>215</fpage>&#x02013;<lpage>226</lpage>.<pub-id pub-id-type="pmid">9631649</pub-id></mixed-citation></ref><ref id="joa12416-bib-0003"><mixed-citation publication-type="journal" id="joa12416-cit-0003">
<string-name>
<surname>Bayatti</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Moss</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. (<year>2008a</year>) <article-title>A molecular neuroanatomical study of the developing human neocortex from 8 to 17 postconceptional weeks revealing the early differentiation of the subplate and subventricular zone</article-title>. <source>Cereb Cortex</source>
<volume>18</volume>, <fpage>1536</fpage>&#x02013;<lpage>1548</lpage>.<pub-id pub-id-type="pmid">17965125</pub-id></mixed-citation></ref><ref id="joa12416-bib-0004"><mixed-citation publication-type="journal" id="joa12416-cit-0004">
<string-name>
<surname>Bayatti</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Sarma</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Shaw</surname>
<given-names>C</given-names>
</string-name>, et&#x000a0;al. (<year>2008b</year>) <article-title>Progressive loss of PAX6, TBR2, NEUROD and TBR1 mRNA gradients correlates with translocation of EMX2 to the cortical plate during human cortical development</article-title>. <source>Eur J Neurosci</source>
<volume>28</volume>, <fpage>1449</fpage>&#x02013;<lpage>1456</lpage>.<pub-id pub-id-type="pmid">18973570</pub-id></mixed-citation></ref><ref id="joa12416-bib-0005"><mixed-citation publication-type="journal" id="joa12416-cit-0005">
<string-name>
<surname>Bedogni</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Hodge</surname>
<given-names>RD</given-names>
</string-name>, <string-name>
<surname>Elsen</surname>
<given-names>GE</given-names>
</string-name>, et&#x000a0;al. (<year>2010</year>) <article-title>Tbr1 regulates regional and laminar identity of postmitotic neurons in developing neocortex</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>107</volume>, <fpage>13&#x02005;129</fpage>&#x02013;<lpage>13&#x02005;134</lpage>.</mixed-citation></ref><ref id="joa12416-bib-0006"><mixed-citation publication-type="journal" id="joa12416-cit-0006">
<string-name>
<surname>Betizeau</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Cortay</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Patti</surname>
<given-names>D</given-names>
</string-name>, et&#x000a0;al. (<year>2013</year>) <article-title>Precursor diversity and complexity of lineage relationships in the outer subventricular zone of the primate</article-title>. <source>Neuron</source>
<volume>80</volume>, <fpage>442</fpage>&#x02013;<lpage>457</lpage>.<pub-id pub-id-type="pmid">24139044</pub-id></mixed-citation></ref><ref id="joa12416-bib-0007"><mixed-citation publication-type="book" id="joa12416-cit-0007">
<string-name>
<surname>Bullen</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Wilson</surname>
<given-names>D</given-names>
</string-name> (<year>1997</year>) <chapter-title>The Carnegie staging of human embryos: a practical guide</chapter-title> In: <source>Molecular Genetics of Early Development</source>. (eds <person-group person-group-type="editor"><name><surname>Strachan</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Lindsay</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Wilson</surname><given-names>DI</given-names></name></person-group>), pp. <fpage>27</fpage>&#x02013;<lpage>35</lpage>. <publisher-loc>Oxford</publisher-loc>: <publisher-name>Bios Scientific Publishers</publisher-name>.</mixed-citation></ref><ref id="joa12416-bib-0008"><mixed-citation publication-type="journal" id="joa12416-cit-0008">
<string-name>
<surname>Capranico</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Tinelli</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Austin</surname>
<given-names>CA</given-names>
</string-name>, et&#x000a0;al. (<year>1992</year>) <article-title>Different patterns of gene expression of topoisomerase II isoforms in differentiated tissues during murine development</article-title>. <source>Biochim Biophys Acta</source>
<volume>1132</volume>, <fpage>43</fpage>&#x02013;<lpage>48</lpage>.<pub-id pub-id-type="pmid">1380833</pub-id></mixed-citation></ref><ref id="joa12416-bib-0009"><mixed-citation publication-type="journal" id="joa12416-cit-0009">
<string-name>
<surname>Dachtler</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Glasper</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Cohen</surname>
<given-names>R</given-names>
</string-name>, et&#x000a0;al. (<year>2014</year>) <article-title>Deletion of [alpha]&#x02010;neurexin II results in autism&#x02010;related behaviors in mice</article-title>. <source>Transl Psychiatry</source>
<volume>4</volume>, <fpage>e484</fpage>.<pub-id pub-id-type="pmid">25423136</pub-id></mixed-citation></ref><ref id="joa12416-bib-0010"><mixed-citation publication-type="journal" id="joa12416-cit-0010">
<string-name>
<surname>Del Bigio</surname>
<given-names>MR</given-names>
</string-name> (<year>2011</year>) <article-title>Cell proliferation in human ganglionic eminence and suppression after prematurity&#x02010;associated haemorrhage</article-title>. <source>Brain</source>
<volume>134</volume>, <fpage>1344</fpage>&#x02013;<lpage>1361</lpage>.<pub-id pub-id-type="pmid">21478186</pub-id></mixed-citation></ref><ref id="joa12416-bib-0011"><mixed-citation publication-type="journal" id="joa12416-cit-0011">
<string-name>
<surname>Englund</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Fink</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Lau</surname>
<given-names>C</given-names>
</string-name>, et&#x000a0;al. (<year>2005</year>) <article-title>Pax6, Tbr2, and Tbr1 are expressed sequentially by radial glia, intermediate progenitor cells, and postmitotic neurons in developing neocortex</article-title>. <source>J Neurosci</source>
<volume>25</volume>, <fpage>247</fpage>&#x02013;<lpage>251</lpage>.<pub-id pub-id-type="pmid">15634788</pub-id></mixed-citation></ref><ref id="joa12416-bib-0012"><mixed-citation publication-type="journal" id="joa12416-cit-0012">
<string-name>
<surname>Feng</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Schroer</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Yan</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. (<year>2006</year>) <article-title>High frequency of neurexin 1&#x003b2; signal peptide structural variants in patients with autism</article-title>. <source>Neurosci Lett</source>
<volume>409</volume>, <fpage>10</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="pmid">17034946</pub-id></mixed-citation></ref><ref id="joa12416-bib-0013"><mixed-citation publication-type="journal" id="joa12416-cit-0013">
<string-name>
<surname>Goto</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Morigaki</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Okita</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. (<year>2015</year>) <article-title>Development of a highly sensitive immunohistochemical method to detect neurochemical molecules in formalin&#x02010;fixed and paraffin&#x02010;embedded tissues from autopsied human brains</article-title>. <source>Front Neuroanat</source>
<volume>9</volume>, <fpage>22</fpage>.<pub-id pub-id-type="pmid">25784860</pub-id></mixed-citation></ref><ref id="joa12416-bib-0014"><mixed-citation publication-type="journal" id="joa12416-cit-0014">
<string-name>
<surname>Grue</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Gr&#x000e4;&#x000df;er</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Sehested</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. (<year>1998</year>) <article-title>Essential mitotic functions of DNA topoisomerase II&#x003b1; are not adopted by topoisomerase II &#x003b2; in human H69 cells</article-title>. <source>J Biol Chem</source>
<volume>273</volume>, <fpage>33&#x02005;660</fpage>&#x02013;<lpage>33&#x02005;666</lpage>.<pub-id pub-id-type="pmid">9417043</pub-id></mixed-citation></ref><ref id="joa12416-bib-0015"><mixed-citation publication-type="journal" id="joa12416-cit-0015">
<string-name>
<surname>Haffner</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Aryee</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Toubaji</surname>
<given-names>A</given-names>
</string-name> (<year>2010</year>) <article-title>Androgen&#x02010;induced TOP2B&#x02010;mediated double&#x02010;strand breaks and prostate cancer gene rearrangements</article-title>. <source>Nat Genet</source>
<volume>42</volume>, <fpage>668</fpage>&#x02013;<lpage>675</lpage>.<pub-id pub-id-type="pmid">20601956</pub-id></mixed-citation></ref><ref id="joa12416-bib-0016"><mixed-citation publication-type="journal" id="joa12416-cit-0016">
<string-name>
<surname>Hansen</surname>
<given-names>DV</given-names>
</string-name>, <string-name>
<surname>Lui</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Flandin</surname>
<given-names>P</given-names>
</string-name>, et&#x000a0;al. (<year>2013</year>) <article-title>Non&#x02010;epithelial stem cells and cortical interneuron production in the human ganglionic eminences</article-title>. <source>Nat Neurosci</source>
<volume>16</volume>, <fpage>1576</fpage>&#x02013;<lpage>1587</lpage>.<pub-id pub-id-type="pmid">24097039</pub-id></mixed-citation></ref><ref id="joa12416-bib-0017"><mixed-citation publication-type="journal" id="joa12416-cit-0017">
<string-name>
<surname>Heck</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Hittelman</surname>
<given-names>WN</given-names>
</string-name>, <string-name>
<surname>Earnshaw</surname>
<given-names>WC</given-names>
</string-name> (<year>1988</year>) <article-title>Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>85</volume>, <fpage>1086</fpage>&#x02013;<lpage>1090</lpage>.<pub-id pub-id-type="pmid">2829215</pub-id></mixed-citation></ref><ref id="joa12416-bib-0018"><mixed-citation publication-type="journal" id="joa12416-cit-0018">
<string-name>
<surname>Hern</surname>
<given-names>WM</given-names>
</string-name> (<year>1984</year>) <article-title>Correlation of foetal age and measurements between 10 and 26&#x000a0;weeks of gestation</article-title>. <source>Obstet Gynecol</source>
<volume>63</volume>, <fpage>26</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="pmid">6691014</pub-id></mixed-citation></ref><ref id="joa12416-bib-0019"><mixed-citation publication-type="journal" id="joa12416-cit-0019">
<string-name>
<surname>Hernandez&#x02010;Miranda</surname>
<given-names>LR</given-names>
</string-name>, <string-name>
<surname>Parnavelas</surname>
<given-names>JG</given-names>
</string-name>, <string-name>
<surname>Chiara</surname>
<given-names>S</given-names>
</string-name> (<year>2010</year>) <article-title>Molecules and mechanisms involved in the generation and migration of cortical interneurons</article-title>. <source>ASN Neuro</source>
<volume>2</volume>, <fpage>e00031</fpage>.<pub-id pub-id-type="pmid">20360946</pub-id></mixed-citation></ref><ref id="joa12416-bib-0020"><mixed-citation publication-type="journal" id="joa12416-cit-0020">
<string-name>
<surname>Ip</surname>
<given-names>BK</given-names>
</string-name>, <string-name>
<surname>Wappler</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Peters</surname>
<given-names>H</given-names>
</string-name>, et&#x000a0;al. (<year>2010</year>) <article-title>Investigating gradients of gene expression involved in early human cortical development</article-title>. <source>J Anat</source>
<volume>217</volume>, <fpage>300</fpage>&#x02013;<lpage>311</lpage>.<pub-id pub-id-type="pmid">20579172</pub-id></mixed-citation></ref><ref id="joa12416-bib-0021"><mixed-citation publication-type="journal" id="joa12416-cit-0021">
<string-name>
<surname>Ip</surname>
<given-names>BK</given-names>
</string-name>, <string-name>
<surname>Bayatti</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Howard</surname>
<given-names>NJ</given-names>
</string-name>, et&#x000a0;al. (<year>2011</year>) <article-title>The corticofugal neuron&#x02010;associated genes ROBO1, SRGAP1, and CTIP2 exhibit an anterior to posterior gradient of expression in early foetal human neocortex development</article-title>. <source>Cereb Cortex</source>
<volume>21</volume>, <fpage>1395</fpage>&#x02013;<lpage>1407</lpage>.<pub-id pub-id-type="pmid">21060114</pub-id></mixed-citation></ref><ref id="joa12416-bib-0022"><mixed-citation publication-type="journal" id="joa12416-cit-0022">
<string-name>
<surname>Isik</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Zaim</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Yildiz</surname>
<given-names>MT</given-names>
</string-name>, et&#x000a0;al. (<year>2015</year>) <article-title>DNA topoisomerase II&#x003b2; as a molecular switch in neural differentiation of mesenchymal stem cells</article-title>. <source>Ann Hematol</source>
<volume>94</volume>, <fpage>307</fpage>&#x02013;<lpage>318</lpage>.<pub-id pub-id-type="pmid">25217229</pub-id></mixed-citation></ref><ref id="joa12416-bib-0023"><mixed-citation publication-type="journal" id="joa12416-cit-0023">
<string-name>
<surname>Ju</surname>
<given-names>BG</given-names>
</string-name>, <string-name>
<surname>Lunyak</surname>
<given-names>VV</given-names>
</string-name>, <string-name>
<surname>Perissi</surname>
<given-names>V</given-names>
</string-name>, et&#x000a0;al. (<year>2006</year>) <article-title>A topoisomerase II beta&#x02010;mediated dsDNA break required for regulated transcription</article-title>. <source>Science</source>
<volume>312</volume>, <fpage>1798</fpage>&#x02013;<lpage>1802</lpage>.<pub-id pub-id-type="pmid">16794079</pub-id></mixed-citation></ref><ref id="joa12416-bib-0024"><mixed-citation publication-type="journal" id="joa12416-cit-0024">
<string-name>
<surname>Kang</surname>
<given-names>HJ</given-names>
</string-name>, <string-name>
<surname>Kawasawa</surname>
<given-names>YI</given-names>
</string-name>, <string-name>
<surname>Cheng</surname>
<given-names>F</given-names>
</string-name>, et&#x000a0;al. (<year>2011</year>) <article-title>Spatio&#x02010;temporal transcriptome of the human brain</article-title>. <source>Nature</source>
<volume>478</volume>, <fpage>483</fpage>&#x02013;<lpage>489</lpage>.<pub-id pub-id-type="pmid">22031440</pub-id></mixed-citation></ref><ref id="joa12416-bib-0025"><mixed-citation publication-type="journal" id="joa12416-cit-0025">
<string-name>
<surname>King</surname>
<given-names>IF</given-names>
</string-name>, <string-name>
<surname>Yandava</surname>
<given-names>CN</given-names>
</string-name>, <string-name>
<surname>Mabb</surname>
<given-names>AM</given-names>
</string-name>, et&#x000a0;al. (<year>2013</year>) <article-title>Topoisomerases facilitate transcription of long genes linked to autism</article-title>. <source>Nature</source>
<volume>501</volume>, <fpage>58</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="pmid">23995680</pub-id></mixed-citation></ref><ref id="joa12416-bib-0026"><mixed-citation publication-type="journal" id="joa12416-cit-0026">
<string-name>
<surname>Konopka</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Wexler</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Rosen</surname>
<given-names>E</given-names>
</string-name>, et&#x000a0;al. (<year>2012</year>) <article-title>Modeling the functional genomics of autism using human neurons</article-title>. <source>Mol Psychiatry</source>
<volume>17</volume>, <fpage>202</fpage>&#x02013;<lpage>214</lpage>.<pub-id pub-id-type="pmid">21647150</pub-id></mixed-citation></ref><ref id="joa12416-bib-0027"><mixed-citation publication-type="journal" id="joa12416-cit-0027">
<string-name>
<surname>Kosodo</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>R&#x004e7;per</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Haubensak</surname>
<given-names>W</given-names>
</string-name>, et&#x000a0;al. (<year>2004</year>) <article-title>Asymmetric distribution of the apical plasma membrane during neurogenic divisions of mammalian neuroepithelial cells</article-title>. <source>EMBO J</source>
<volume>23</volume>, <fpage>2314</fpage>&#x02013;<lpage>2324</lpage>.<pub-id pub-id-type="pmid">15141162</pub-id></mixed-citation></ref><ref id="joa12416-bib-0028"><mixed-citation publication-type="journal" id="joa12416-cit-0028">
<string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hao</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Tzatzalos</surname>
<given-names>E</given-names>
</string-name>, et&#x000a0;al. (<year>2014</year>) <article-title>Topoisomerase IIbeta is required for proper retinal development and survival of postmitotic cells</article-title>. <source>Biol Open</source>
<volume>3</volume>, <fpage>172</fpage>&#x02013;<lpage>184</lpage>.<pub-id pub-id-type="pmid">24463367</pub-id></mixed-citation></ref><ref id="joa12416-bib-0029"><mixed-citation publication-type="journal" id="joa12416-cit-0029">
<string-name>
<surname>Lui</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Hansen</surname>
<given-names>DV</given-names>
</string-name>, <string-name>
<surname>Kriegstein</surname>
<given-names>AR</given-names>
</string-name> (<year>2011</year>) <article-title>Development and evolution of the human neocortex</article-title>. <source>Cell</source>
<volume>146</volume>, <fpage>18</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="pmid">21729779</pub-id></mixed-citation></ref><ref id="joa12416-bib-0030"><mixed-citation publication-type="journal" id="joa12416-cit-0030">
<string-name>
<surname>Lyu</surname>
<given-names>YL</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>JC</given-names>
</string-name> (<year>2003</year>) <article-title>Aberrant lamination in the cerebral cortex of mouse embryos lacking DNA topoisomerase IIbeta</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>100</volume>, <fpage>7123</fpage>&#x02013;<lpage>7128</lpage>.<pub-id pub-id-type="pmid">12773624</pub-id></mixed-citation></ref><ref id="joa12416-bib-0031"><mixed-citation publication-type="journal" id="joa12416-cit-0031">
<string-name>
<surname>Marin</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Anderson</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Rubenstein</surname>
<given-names>JL</given-names>
</string-name> (<year>2000</year>) <article-title>Origin and molecular specification of striatal interneurons</article-title>. <source>J Neurosci</source>
<volume>20</volume>, <fpage>6063</fpage>&#x02013;<lpage>6076</lpage>.<pub-id pub-id-type="pmid">10934256</pub-id></mixed-citation></ref><ref id="joa12416-bib-0032"><mixed-citation publication-type="journal" id="joa12416-cit-0032">
<string-name>
<surname>McNamara</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Nichol</surname>
<given-names>JN</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>H</given-names>
</string-name>, et&#x000a0;al. (<year>2010</year>) <article-title>Targeting PKC delta&#x02010;mediated topII beta overexpression subverts the differentiation block in a retinoic acid&#x02010;resistant APL cell line</article-title>. <source>Leukemia</source>
<volume>24</volume>, <fpage>729</fpage>&#x02013;<lpage>739</lpage>.<pub-id pub-id-type="pmid">20200558</pub-id></mixed-citation></ref><ref id="joa12416-bib-0033"><mixed-citation publication-type="journal" id="joa12416-cit-0033">
<string-name>
<surname>Meyer</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Schaaps</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Moreau</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. (<year>2000</year>) <article-title>Embryonic and early foetal development of the human neocortex</article-title>. <source>J Neurosci</source>
<volume>20</volume>, <fpage>1858</fpage>&#x02013;<lpage>1868</lpage>.<pub-id pub-id-type="pmid">10684887</pub-id></mixed-citation></ref><ref id="joa12416-bib-0034"><mixed-citation publication-type="journal" id="joa12416-cit-0034">
<string-name>
<surname>Negri</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Chiesa</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Cerino</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. (<year>1992</year>) <article-title>Monoclonal antibodies to human DNA topoisomerase I and the two isoforms of DNA topoisomerase II, 170&#x02010; and 180&#x02010;kDa isozymes</article-title>. <source>Exp Cell Res</source>
<volume>200</volume>, <fpage>452</fpage>&#x02013;<lpage>459</lpage>.<pub-id pub-id-type="pmid">1315288</pub-id></mixed-citation></ref><ref id="joa12416-bib-0035"><mixed-citation publication-type="journal" id="joa12416-cit-0035">
<string-name>
<surname>Nevin</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Xiao</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Staub</surname>
<given-names>W</given-names>
</string-name>, et&#x000a0;al. (<year>2011</year>) <article-title>Topoisomerase IIbeta is required for lamina&#x02010;specific targeting of retinal ganglion cell axons and dendrites</article-title>. <source>Development</source>
<volume>138</volume>, <fpage>2457</fpage>&#x02013;<lpage>2465</lpage>.<pub-id pub-id-type="pmid">21610027</pub-id></mixed-citation></ref><ref id="joa12416-bib-0036"><mixed-citation publication-type="journal" id="joa12416-cit-0036">
<string-name>
<surname>Nitiss</surname>
<given-names>JL</given-names>
</string-name> (<year>2009a</year>) <article-title>DNA topoisomerase II and its growing repertoire of biological functions</article-title>. <source>Nat Rev Cancer</source>
<volume>9</volume>, <fpage>327</fpage>&#x02013;<lpage>337</lpage>.<pub-id pub-id-type="pmid">19377505</pub-id></mixed-citation></ref><ref id="joa12416-bib-0037"><mixed-citation publication-type="journal" id="joa12416-cit-0037">
<string-name>
<surname>Nitiss</surname>
<given-names>JL</given-names>
</string-name> (<year>2009b</year>) <article-title>Targeting DNA topoisomerase II in cancer chemotherapy</article-title>. <source>Nat Rev Cancer</source>
<volume>9</volume>, <fpage>338</fpage>&#x02013;<lpage>350</lpage>.<pub-id pub-id-type="pmid">19377506</pub-id></mixed-citation></ref><ref id="joa12416-bib-0038"><mixed-citation publication-type="journal" id="joa12416-cit-0038">
<string-name>
<surname>Nur&#x02010;E&#x02010;Kamal</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Meiners</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ahmed</surname>
<given-names>I</given-names>
</string-name>, et&#x000a0;al. (<year>2007</year>) <article-title>Role of DNA topoisomerase II&#x003b2; in neurite outgrowth</article-title>. <source>Brain Res</source>
<volume>1154</volume>, <fpage>50</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="pmid">17493591</pub-id></mixed-citation></ref><ref id="joa12416-bib-0039"><mixed-citation publication-type="journal" id="joa12416-cit-0039">
<string-name>
<surname>O'Rahilly</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>M&#x000fc;ller</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Hutchins</surname>
<given-names>GM</given-names>
</string-name>, et&#x000a0;al. (<year>1987</year>) <article-title>Computer ranking of the sequence of appearance of 73 features of the brain and related structures in staged human embryos during the sixth week of development</article-title>. <source>Am J Anat</source>
<volume>180</volume>, <fpage>69</fpage>&#x02013;<lpage>86</lpage>.<pub-id pub-id-type="pmid">3661464</pub-id></mixed-citation></ref><ref id="joa12416-bib-0040"><mixed-citation publication-type="journal" id="joa12416-cit-0040">
<string-name>
<surname>Pauly</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>D&#x004e7;br&#x004e7;ssy</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>Nikkhah</surname>
<given-names>G</given-names>
</string-name>, et&#x000a0;al. (<year>2014</year>) <article-title>Organization of the human foetal subpallium</article-title>. <source>Front Neuroanat</source>
<volume>7</volume>, <fpage>54</fpage>.<pub-id pub-id-type="pmid">24474906</pub-id></mixed-citation></ref><ref id="joa12416-bib-0041"><mixed-citation publication-type="journal" id="joa12416-cit-0041">
<string-name>
<surname>Perillo</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Ombra</surname>
<given-names>MN</given-names>
</string-name>, <string-name>
<surname>Bertoni</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. (<year>2008</year>) <article-title>DNA oxidation as triggered by H3K9me2 demethylation drives estrogen&#x02010;induced gene expression</article-title>. <source>Science</source>
<volume>319</volume>, <fpage>202</fpage>&#x02013;<lpage>206</lpage>.<pub-id pub-id-type="pmid">18187655</pub-id></mixed-citation></ref><ref id="joa12416-bib-0042"><mixed-citation publication-type="journal" id="joa12416-cit-0042">
<string-name>
<surname>Plaschkes</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Silverman</surname>
<given-names>FW</given-names>
</string-name>, <string-name>
<surname>Priel</surname>
<given-names>E</given-names>
</string-name> (<year>2005</year>) <article-title>DNA topoisomerase I in the mouse central nervous system, age and sex dependence</article-title>. <source>J Comp Neurol</source>
<volume>493</volume>, <fpage>357</fpage>&#x02013;<lpage>369</lpage>.<pub-id pub-id-type="pmid">16261531</pub-id></mixed-citation></ref><ref id="joa12416-bib-0043"><mixed-citation publication-type="journal" id="joa12416-cit-0043">
<string-name>
<surname>Rakic</surname>
<given-names>P</given-names>
</string-name> (<year>2009</year>) <article-title>Evolution of the neocortex: a perspective from developmental biology</article-title>. <source>Nat Rev Neurosci</source>
<volume>10</volume>, <fpage>724</fpage>&#x02013;<lpage>735</lpage>.<pub-id pub-id-type="pmid">19763105</pub-id></mixed-citation></ref><ref id="joa12416-bib-0044"><mixed-citation publication-type="journal" id="joa12416-cit-0044">
<string-name>
<surname>Scholzen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Gerdes</surname>
<given-names>J</given-names>
</string-name> (<year>2000</year>) <article-title>The Ki&#x02010;67 protein, from the known and the unknown</article-title>. <source>J Cell Physiol</source>
<volume>182</volume>, <fpage>311</fpage>&#x02013;<lpage>322</lpage>.<pub-id pub-id-type="pmid">10653597</pub-id></mixed-citation></ref><ref id="joa12416-bib-0045"><mixed-citation publication-type="journal" id="joa12416-cit-0045">
<string-name>
<surname>Szatmari</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Paterson</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>Zwaigenbaul</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. (<year>2007</year>) <article-title>Mapping autism risk loci using genetic linkage and chromosomal rearrangements</article-title>. <source>Nat Genet</source>
<volume>39</volume>, <fpage>319</fpage>&#x02013;<lpage>328</lpage>.<pub-id pub-id-type="pmid">17322880</pub-id></mixed-citation></ref><ref id="joa12416-bib-0046"><mixed-citation publication-type="journal" id="joa12416-cit-0046">
<string-name>
<surname>Tarsitano</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ceqlia</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Novelli</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. (<year>2014</year>) <article-title>Microduplications in 22q11.2 and 8q22.1 associated with mild mental retardation and generalized overgrowth</article-title>. <source>Gene</source>
<volume>15</volume>, <fpage>213</fpage>&#x02013;<lpage>216</lpage>.<pub-id pub-id-type="pmid">24315824</pub-id></mixed-citation></ref><ref id="joa12416-bib-0047"><mixed-citation publication-type="journal" id="joa12416-cit-0047">
<string-name>
<surname>Taverna</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Huttner</surname>
<given-names>WB</given-names>
</string-name> (<year>2010</year>) <article-title>Neural progenitor nuclei IN motion</article-title>. <source>Neuron</source>
<volume>67</volume>, <fpage>906</fpage>&#x02013;<lpage>914</lpage>.<pub-id pub-id-type="pmid">20869589</pub-id></mixed-citation></ref><ref id="joa12416-bib-0048"><mixed-citation publication-type="journal" id="joa12416-cit-0048">
<string-name>
<surname>Thakurela</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Garding</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Jung</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. (<year>2013</year>) <article-title>Gene regulation and priming by topoisomerase II&#x003b1; in embryonic stem cells</article-title>. <source>Nat Commun</source>
<volume>4</volume>, <fpage>1</fpage>&#x02013;<lpage>13</lpage>.</mixed-citation></ref><ref id="joa12416-bib-0049"><mixed-citation publication-type="journal" id="joa12416-cit-0049">
<string-name>
<surname>Tiwari</surname>
<given-names>VK</given-names>
</string-name>, <string-name>
<surname>Burger</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Nikoletopoulou</surname>
<given-names>V</given-names>
</string-name>, et&#x000a0;al. (<year>2012</year>) <article-title>Target genes of Topoisomerase IIbeta regulate neuronal survival and are defined by their chromatin state</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>109</volume>, <fpage>E934</fpage>&#x02013;<lpage>E943</lpage>.<pub-id pub-id-type="pmid">22474351</pub-id></mixed-citation></ref><ref id="joa12416-bib-0050"><mixed-citation publication-type="journal" id="joa12416-cit-0050">
<string-name>
<surname>Tsutsui</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Tsutsui</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Okada</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. (<year>1993</year>) <article-title>Molecular cloning of partial cDNAs for rat DNA topoisomerase II isoforms and their differential expression in brain development</article-title>. <source>J Biol Chem</source>
<volume>268</volume>, <fpage>19&#x02005;076</fpage>&#x02013;<lpage>19&#x02005;083</lpage>.</mixed-citation></ref><ref id="joa12416-bib-0051"><mixed-citation publication-type="journal" id="joa12416-cit-0051">
<string-name>
<surname>Vaags</surname>
<given-names>AK</given-names>
</string-name>, <string-name>
<surname>Lionel</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Sato</surname>
<given-names>D</given-names>
</string-name>, et&#x000a0;al. (<year>2012</year>) <article-title>Rare deletions at the neurexin 3 locus in autism spectrum disorder</article-title>. <source>Am J Hum Genet</source>
<volume>90</volume>, <fpage>133</fpage>&#x02013;<lpage>141</lpage>.<pub-id pub-id-type="pmid">22209245</pub-id></mixed-citation></ref><ref id="joa12416-bib-0052"><mixed-citation publication-type="journal" id="joa12416-cit-0052">
<string-name>
<surname>Wang</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Long</surname>
<given-names>GE</given-names>
</string-name>, <string-name>
<surname>Flandin</surname>
<given-names>P</given-names>
</string-name>, et&#x000a0;al. (<year>2013</year>) <article-title>Loss of Gsx1 and Gsx2 function rescues distinct phenotypes in Dlx1/2 mutants</article-title>. <source>J Comp Neurol</source>
<volume>521</volume>, <fpage>1561</fpage>&#x02013;<lpage>1564</lpage>.<pub-id pub-id-type="pmid">23042297</pub-id></mixed-citation></ref><ref id="joa12416-bib-0053"><mixed-citation publication-type="journal" id="joa12416-cit-0053">
<string-name>
<surname>Watanabe</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tsutsui</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Tsutsui</surname>
<given-names>K</given-names>
</string-name>, et&#x000a0;al. (<year>1994</year>) <article-title>Differential expressions of the topoisomerase II alpha and II beta mRNAs in developing rat brain</article-title>. <source>Neurosci Res</source>
<volume>19</volume>, <fpage>51</fpage>&#x02013;<lpage>57</lpage>.<pub-id pub-id-type="pmid">8008235</pub-id></mixed-citation></ref><ref id="joa12416-bib-0054"><mixed-citation publication-type="journal" id="joa12416-cit-0054">
<string-name>
<surname>Woessner</surname>
<given-names>RD</given-names>
</string-name>, <string-name>
<surname>Mattern</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Mirabelli</surname>
<given-names>CK</given-names>
</string-name>, et&#x000a0;al. (<year>1991</year>) <article-title>Proliferation&#x02010; and cell cycle&#x02010;dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH&#x02010;3T3 cells</article-title>. <source>Cell Growth Differ</source>
<volume>2</volume>, <fpage>209</fpage>&#x02013;<lpage>214</lpage>.<pub-id pub-id-type="pmid">1651102</pub-id></mixed-citation></ref><ref id="joa12416-bib-0055"><mixed-citation publication-type="journal" id="joa12416-cit-0055">
<string-name>
<surname>Xu</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Tam</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Anderson</surname>
<given-names>SA</given-names>
</string-name> (<year>2008</year>) <article-title>Fate mapping Nkx2.1&#x02010;lineage cells in the mouse telencephalon</article-title>. <source>J Comp Neurol</source>
<volume>506</volume>, <fpage>16</fpage>&#x02013;<lpage>29</lpage>.<pub-id pub-id-type="pmid">17990269</pub-id></mixed-citation></ref><ref id="joa12416-bib-0056"><mixed-citation publication-type="journal" id="joa12416-cit-0056">
<string-name>
<surname>Xu</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>R</given-names>
</string-name>, et&#x000a0;al. (<year>2013</year>) <article-title>Top3beta is an RNA topoisomerase that works with fragile X syndrome protein to promote synapse formation</article-title>. <source>Nat Neurosci</source>
<volume>16</volume>, <fpage>1238</fpage>&#x02013;<lpage>1247</lpage>.<pub-id pub-id-type="pmid">23912945</pub-id></mixed-citation></ref><ref id="joa12416-bib-0057"><mixed-citation publication-type="journal" id="joa12416-cit-0057">
<string-name>
<surname>Yan</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Noltner</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Feng</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. (<year>2008</year>) <article-title>Neurexin 1&#x003b1; structural&#x000a0;variants associated with autism</article-title>. <source>Neurosci Lett</source>
<volume>438</volume>, <fpage>368</fpage>&#x02013;<lpage>370</lpage>.<pub-id pub-id-type="pmid">18490107</pub-id></mixed-citation></ref><ref id="joa12416-bib-0058"><mixed-citation publication-type="journal" id="joa12416-cit-0058">
<string-name>
<surname>Yang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Prescott</surname>
<given-names>ED</given-names>
</string-name>, et&#x000a0;al. (<year>2000</year>) <article-title>DNA topoisomerase II&#x003b2; and neural development</article-title>. <source>Science</source>
<volume>287</volume>, <fpage>131</fpage>&#x02013;<lpage>134</lpage>.<pub-id pub-id-type="pmid">10615047</pub-id></mixed-citation></ref><ref id="joa12416-bib-0059"><mixed-citation publication-type="journal" id="joa12416-cit-0059">
<string-name>
<surname>Zandvliet</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Hanby</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Austin</surname>
<given-names>CA</given-names>
</string-name>, et&#x000a0;al. (<year>1996</year>) <article-title>Analysis of foetal expression sites of human type II DNA topoisomerase alpha and beta mRNAs by <italic>in&#x000a0;situ</italic> hybridisation</article-title>. <source>Biochim Biophys Acta</source>
<volume>1307</volume>, <fpage>239</fpage>&#x02013;<lpage>247</lpage>.<pub-id pub-id-type="pmid">8679710</pub-id></mixed-citation></ref></ref-list></back></article>